Ready-to-Recruit" or "Ready-to-Consent" Populations? Informed Consent and the Limits of Subject Autonomy
Dados Bibliográficos
| ID | 2385183 |
|---|---|
| Autores | Jill A Fisher (0000-0002-9487-1493, Arizona State University) |
| Ano | 2007 |
| Volume | 13 |
| Fascículo | 6 |
| Páginas | 875-894 |
| Data de publicação | 2007-09-01 |
| Peer Reviewed | Sim |
| Open Access | Sim |
| Tipo | ARTICLE |
| Periódico | Qualitative Inquiry (JOURNAL) |
| Identificadores do periódico | ISSN: 1077-8004 • E-ISSN: 1552-7565 |
| Editora | SAGE Publications Inc (PUBLISHER) |
| DOI | 10.1177/1077800407304460 |
| PMID | 21359125 |
| PMCID | PMC3044324 |
| OpenAlex | W2084313708 |
| Idioma | EN |
| Citações recebidas | 16 |
| Referências citadas | 18 |
This article queries the pharmaceutical industry's concept of "ready-torecruit" populations by examining its recruitment strategies for clinical trials and the types of human subjects who participate in these drug studies. The argument is that the pharmaceutical industry has profited from a system composed of what can more aptly be characterized as ready-to-consent populations, meaning populations who do not have better alternatives than participation in clinical trials. Furthermore, through qualitative research, this article aims to highlight some of the limitations of current U.S. federal regulation and to show how these limits signal problems that are not normally discussed in the medical ethics literature about research on human subjects. It does this by examining the impotence of informed consent-both as a concept and as a practice-in light of recruitment strategies and the structural reasons motivating individuals to participate in clinical trials
Alternative medicine · Argument (complex analysis · Autonomy · Biobank · Bioinformatics · Clinical trial · Engineering ethics · Informed consent · Meaning (existential · Medical education · Pathology · Pharmaceutical industry · Political science · Psychiatry · Psychotherapist · Public relations · Qualitative research · Research ethics · Social science · Sociology · Subject (documents · Biomedical Ethics and Regulation · Ethics in Clinical Research · Law · Medicine · Pharmaceutical industry and healthcare · Psychology · Pharmacology
(Re)configuring research value
Standardising Patient Engagement in Drug Development
This isn’t going to end well
Racing for Consent
From people with dementia to people with data
A Systematic Review of Barriers and Facilitators to Minority Research Participation Among African Americans, Latinos, Asian Americans, and Pacific Islanders
Ethics and Epistemic Injustice in the Global South
A Missing Piece in Clinical Trial Inspections in Latin America
Somatic Surveillance
Risk and Emotion Among Healthy Volunteers in Clinical Trials
Challenging Assumptions About Minority Participation in US Clinical Research
I'm still a hustler
Ready for What
Practicing research ethics
Strategies of inclusion
Configuring the patient as clinical research subject in the UK national health service
Inclusion
Distrust, Race, and Research
Lesser Harms
Ask Your Doctor About
The Contract Research Organization and the Commercialization of Scientific Research
The Rise of `Recruitmentology
From margins to center? The development and purpose of participatory research
Under the shadow of Tuskegee
Bodily Differences and Collective Identities
Co-ordinating 'ethical' clinical trials
Empty ethics
| Obras citantes distintas | 16 |
|---|---|
| Citações por ano | 0,67 |
| Intervalo de citações | 2002 - 2024 (23) |
| Velocidade de citação | recent |
| Altamente citado | Não |
| Tipos de citação | Neutras: 15 |